A 2023 review of six clinical trials found that semaglutide use resulted in systolic BP that was about 5 mmHg lower and diastolic BP that was about 2.5 mmHg lower than in placebo groups
These drugs appear effective for certain populations, although they are prescribed at higher doses than what the body naturally produces 3
This can cause symptoms like weight loss, rapid heartbeat, sweating, and anxiety
veterans with T2DM, reporting that metformin therapy lasting more than 4 years significantly decreased the risk of developing both PD and AD (Shi et al., 2019)
It avoids medical claims or usage guidance and instead summarises peptide classification and areas of laboratory investigation
When looking at specific mental health conditions, semaglutide use was linked to significantly lower risks of worsening depression, anxiety, and substance use disorders